A. Voronina

Predictive Validation of Patient-Derived 3D-Bioprinted Tumor Models for Precision Oncology: Current Evidence, Translational Gaps, and Future Standards

Pat-derived 3D-bioprinted tumor models represent promising human-relevant preclinical platforms, but their predictive validity remains insufficient for routine treatment selection.